Hope-Focused therapy may help young cancer survivors cope

NCT ID NCT06941324

Recruiting now Symptom relief Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study tests whether a short, hope-based therapy called solution-focused brief therapy (SFBT) can reduce psychological distress in adolescents and young adults who have had cancer. About 60 survivors aged 15-39 with mild to moderate distress will receive either SFBT or enhanced usual care. The goal is to see if SFBT improves emotional well-being and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: solution-focused brief therapy (SFBT-C)
What this could lead to: If it works, this could provide a short, hope-based therapy option to ease anxiety and depression in young cancer survivors.
What could go wrong: This is a small early-stage trial (60 participants) testing a behavioral intervention, so results may not apply broadly. The therapy may not outperform usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM MALIGNANT SOLID NEOPLASM

Contacts and locations

Locations

University of Michigan Comprehensive Cancer Center
RECRUITING

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.